ArticleFrontiers in urology2026
Case Report: Dual giant neobladder stones weighing 950 grams following 18-year loss to follow-up: surgical management and prevention strategies.
Article in Frontiers in urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Giant bladder stone presenting with renal failure 15 years after ileocystoplasty augmentation: A case report.Urology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neobladder urolithiasis represents a significant long-term complication following radical cystectomy with orthotopic reconstruction, with incidence ranging from 3-9% for ileal neobladders to as high as 43% for Kock pouch configurations. Giant stones are rare and usually result from prolonged gaps in surveillance combined with inadequate preventive measures. Patient presentation: This is a case of a 78-year-old male presenting with progressive lower urinary tract symptoms after 18 years without urological follow-up following radical cystoprostatectomy and ileal neobladder reconstruction for muscle-invasive bladder cancer (pT2N0M0) performed in 2006. He had relocated geographically one year post-surgery and stopped all urological care, never performing self-catheterization or bladder irrigation as instructed. Computed tomography revealed two massive neobladder stones measuring 10×8×6 cm and 9×7×8 cm with 1,300 Hounsfield Units density. Open cystolithotomy successfully removed both calculi with a combined weight of 950 grams in 90 minutes with minimal blood loss of 100 mL and no complications. Stone analysis confirmed a pure struvite-carbonate apatite composition secondary to chronic Proteus mirabilis infection. The patient was discharged on postoperative day 3. Follow-up at 1, 3, 6, and 12 months demonstrated complete symptom resolution, stone-free status on imaging, and stable renal function. However, the patient was subsequently lost to follow-up again after 12 months despite multiple attempts at contact. Conclusions: This case, representing one of the heaviest dual-stone presentations documented in neobladder patients (950g combined weight), demonstrates that complete surgical excision via open cystolithotomy remains the treatment of choice for giant neobladder calculi. The exceptionally prolonged 18-year surveillance gap enabled progressive bilateral stone development, emphasizing the absolute necessity of lifelong structured follow-up programs for all urinary diversion patients. Comprehensive preventive strategies including daily bladder irrigation with 500-1000 mL normal saline, adequate hydration (≥2.5 L daily), aggressive infection control with surveillance cultures every 3-6 months and suppressive antibiotic prophylaxis when indicated, and regular imaging surveillance are essential to prevent such severe complications. Even after prolonged follow-up loss and massive stone development, curative intervention can achieve excellent outcomes when patients subsequently engage with comprehensive preventive protocols, as demonstrated by this patient's stone-free status during the 12-month compliant period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.